The channel is composed of RYR2 homotetramers andFK506-binding proteinsfound in a 1:4 stoichiometric ratio. Calcium channel function is affected by the specific type of FK506 isomer interacting with the RYR2 protein, due to binding differences and other factors.
Function
The RYR2 protein functions as the major component of a calcium channel located in the sarcoplasmic reticulum that supplies ions to the cardiac muscle during systole.To enable cardiac muscle contraction, calcium influx through voltage-gatedL-type calcium channelsin the plasma membrane allows calcium ions to bind to RYR2 located on thesarcoplasmic reticulum. This binding causes the release of calcium through RYR2 from the sarcoplasmic reticulum into the cytosol, where it binds to the C domain oftroponin, which shifts tropomyosin and allows the myosinATPase to bind to actin, enabling cardiac muscle contraction. RYR2 channels are associated with many cellular functions, including mitochondrial metabolism, gene expression and cell survival, in addition to their role in cardiomyocyte contraction.
Clinical significance
Deleterious mutations of the ryanodine receptor family, and especially the RYR2 receptor, lead to a constellation of pathologies leading to both acute and chronic heart failure collectively known as "Ryanopathies."
Recently, sudden cardiac death in several young individuals in the Amish community (four of which were from the same family) was traced to homozygous duplication of a mutant RyR2 gene. Normal (wild type) RyR2 functions primarily in the myocardium (heart muscle).
Mice with genetically reduced RYR2 exhibit a lower basal heart rate and fatal arrhythmias.
Interactions
Ryanodine receptor 2 has been shown to interact with:
↑Wehrens XH, Lehnart SE, Reiken SR, Marks AR (April 2004). "Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor". Circulation Research. 94 (6): e61–e70. doi:10.1161/01.RES.0000125626.33738.E2. PMID15016728.
Ogawa Y, Kurebayashi N, Murayama T (1999). "Ryanodine receptor isoforms in excitation-contraction coupling". Advances in Biophysics. 36: 27–64. doi:10.1016/S0065-227X(99)80004-5. PMID10463072.
Danieli GA, Rampazzo A (May 2002). "Genetics of arrhythmogenic right ventricular cardiomyopathy". Current Opinion in Cardiology. 17 (3): 218–221. doi:10.1097/00001573-200205000-00002. PMID12015469.
Ma J, Hayek SM, Bhat MB (2005). "Membrane topology and membrane retention of the ryanodine receptor calcium release channel". Cell Biochemistry and Biophysics. 40 (2): 207–224. doi:10.1385/CBB:40:2:207. PMID15054223. S2CID25375622.
Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, etal. (November 1995). "A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43". Human Molecular Genetics. 4 (11): 2151–2154. doi:10.1093/hmg/4.11.2151. hdl:11577/2463114. PMID8589694.
Martin C, Chapman KE, Seckl JR, Ashley RH (July 1998). "Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum". Neuroscience. 85 (1): 205–216. doi:10.1016/S0306-4522(97)00612-X. PMID9607712. S2CID25634042.
Mori F, Fukaya M, Abe H, Wakabayashi K, Watanabe M (May 2000). "Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain". Neuroscience Letters. 285 (1): 57–60. doi:10.1016/S0304-3940(00)01046-6. PMID10788707. S2CID32514035.